Assembly Biosciences, Inc.
ASMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $94,752 | $45,041 | $62,932 | $1,301,121 |
| - Cash | $38,344 | $19,841 | $52,418 | $45,627 |
| + Debt | $3,089 | $2,342 | $3,465 | $6,476 |
| Enterprise Value | $59,497 | $27,542 | $13,979 | $1,261,970 |
| Revenue | $28,520 | $7,163 | $0 | $6,254 |
| % Growth | 298.2% | – | -100% | – |
| Gross Profit | $28,520 | -$41,737 | -$69,080 | $6,254 |
| % Margin | 100% | -582.7% | – | 100% |
| EBITDA | -$45,291 | -$64,196 | -$92,516 | -$90,584 |
| % Margin | -158.8% | -896.2% | – | -1,448.4% |
| Net Income | -$40,177 | -$61,228 | -$93,092 | -$129,855 |
| % Margin | -140.9% | -854.8% | – | -2,076.4% |
| EPS Diluted | -6.69 | -13.38 | -22.82 | -36 |
| % Growth | 50% | 41.4% | 36.6% | – |
| Operating Cash Flow | -$51,117 | $22,743 | -$84,463 | -$93,396 |
| Capital Expenditures | -$28 | -$255 | -$102 | -$3,096 |
| Free Cash Flow | -$51,145 | $22,488 | -$84,565 | -$96,492 |